Latest Peptide Research
Stay informed about the latest research and developments
Filter Articles
Recent research on GH-FRAG 176-191: Opioid misuse and mental health in college student populations: A national assessment.
Endocrine research examining gonadorelin's (synthetic GnRH) receptor binding and pituitary gonadotropin release mechanisms. Analyzes LH and FSH secretion patterns, receptor desensitization, and pulsatile signaling in pituitary cell cultures.
Recent research on GH-FRAG 176-191: A jasmonate-mediated regulatory network modulates diurnal floret opening time in rice.
Recent research on Tesamorelin: Efficacy and safety of tesamorelin in people with HIV on integrase inhibitors.
Recent research on FOXO4-DRI: FOXO4-DRI improves spermatogenesis in aged mice through reducing senescence-associated secretory phenotype secretion from Leydig cells.
Recent research on Ipamorelin: The growth hormone secretagogue receptor 1a agonists, anamorelin and ipamorelin, inhibit cisplatin-induced weight loss in ferrets: Anamorelin also exhibits anti-emetic effects via a central mechanism.
Preclinical investigation of thymosin alpha-1's immunomodulatory mechanisms including T-cell maturation, cytokine production modulation, and immune response enhancement. Examines potential applications in immune system support and infection resistance.
Recent research on Melanotan II: Recommended Tool Compounds for the Melanocortin Receptor (MCR) G Protein-Coupled Receptors (GPCRs).
Endocrinology research examining tirzepatide's dual GLP-1 and GIP receptor agonism. Investigates glucose-dependent insulin secretion, glucagon suppression, and metabolic pathway modulation in pancreatic cell culture models.
Recent research on ARA-290: The protective effect of erythropoietin and its novel derived peptides in peripheral nerve injury.
Recent research on Ipamorelin: The influence of ghrelin agonist ipamorelin acetate on the hypothalamic-pituitary-testicular axis in a cichlid fish, Oreochromis mossambicus.
Recent research on GHRP-2: Robust growth hormone responses to GH-releasing peptide 2 in adolescents.
